These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33605573)

  • 1. GPBAR1 Promotes Proliferation of Serous Ovarian Cancer by Inducing Smad4 Ubiquitination.
    Li H; Zhao J; Shi X
    Appl Immunohistochem Mol Morphol; 2021 Aug; 29(7):519-526. PubMed ID: 33605573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and Clinical Significance of Microtubule-Actin Cross-Linking Factor 1 in Serous Ovarian Cancer.
    Liu L; Hu K; Zeng Z; Xu C; Lv J; Lin Z; Wen B
    Recent Pat Anticancer Drug Discov; 2021; 16(1):66-72. PubMed ID: 33573562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
    Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
    J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis.
    Yang M; Xie X; Ding Y
    Oncol Rep; 2016 Mar; 35(3):1796-806. PubMed ID: 26750614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPBAR1 promotes proliferation and is related to poor prognosis of high-grade glioma via inducing MAFB expression.
    Sun S; Guo H; Liang N; Wu T; Zhang C; Li H
    Histol Histopathol; 2022 Mar; 37(3):251-260. PubMed ID: 34904217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LGR4 overexpression is associated with clinical parameters and poor prognosis of serous ovarian cancer.
    Zeng Z; Ji N; Yi J; Lv J; Yuan J; Lin Z; Liu L; Feng X
    Cancer Biomark; 2020; 28(1):65-72. PubMed ID: 32176632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. POZ/BTB and AT-Hook-Containing Zinc Finger Protein 1 (PATZ1) Suppresses Progression of Ovarian Cancer and Serves as an Independent Prognosis Factor.
    Zhao C; Yan M; Li C; Feng Z
    Med Sci Monit; 2018 Jun; 24():4262-4270. PubMed ID: 29926841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.
    Liang Q; Tang C; Tang M; Zhang Q; Gao Y; Ge Z
    J Exp Clin Cancer Res; 2019 Apr; 38(1):159. PubMed ID: 30979374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA LIFR-AS1 overexpression suppressed the progression of serous ovarian carcinoma.
    Liu F; Cao L; Zhang Y; Xia X; Ji Y
    J Clin Lab Anal; 2022 Aug; 36(8):e25470. PubMed ID: 35778954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-145-5p regulates the proliferation of epithelial ovarian cancer cells via targeting SMAD4.
    Zhou J; Zhang X; Li W; Chen Y
    J Ovarian Res; 2020 May; 13(1):54. PubMed ID: 32366274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of glia maturation factor beta as an independent prognostic predictor for serous ovarian cancer.
    Li YL; Ye F; Cheng XD; Hu Y; Zhou CY; Lü WG; Xie X
    Eur J Cancer; 2010 Jul; 46(11):2104-18. PubMed ID: 20547056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines.
    Carino A; Graziosi L; D'Amore C; Cipriani S; Marchianò S; Marino E; Zampella A; Rende M; Mosci P; Distrutti E; Donini A; Fiorucci S
    Oncotarget; 2016 Sep; 7(38):61021-61035. PubMed ID: 27409173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-183 modulated cell proliferation and apoptosis in ovarian cancer through the TGF-β/Smad4 signaling pathway.
    Zhou J; Zhang C; Zhou B; Jiang D
    Int J Mol Med; 2019 Apr; 43(4):1734-1746. PubMed ID: 30720057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin specific peptidase 5 promotes ovarian cancer cell proliferation through deubiquitinating HDAC2.
    Du Y; Lin J; Zhang R; Yang W; Quan H; Zang L; Han Y; Li B; Sun H; Wu J
    Aging (Albany NY); 2019 Nov; 11(21):9778-9793. PubMed ID: 31727867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of cyclase-associated actin cytoskeleton regulatory protein 2 in epithelial ovarian cancer correlates with aggressive histologic types and worse outcomes.
    Adachi M; Masugi Y; Yamazaki K; Emoto K; Kobayashi Y; Tominaga E; Banno K; Aoki D; Sakamoto M
    Jpn J Clin Oncol; 2020 Jun; 50(6):643-652. PubMed ID: 32211793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA HAL suppresses the migration and invasion of serous ovarian cancer by inhibiting EMT signaling pathway.
    Wu K; Li L; Li L; Wang D
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer.
    Gao C; Yao H; Liu H; Feng Y; Yang Z
    BMC Cancer; 2019 Mar; 19(1):237. PubMed ID: 30876464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of miR-141 and miR-200a Increase
    Wahab NA; Othman Z; Nasri NWM; Mokhtar MH; Ibrahim SF; Hamid AA; Raja Ali RA; Mokhtar NM
    Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32316405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Non-coding RNA
    Yim GW; Kim HJ; Kim LK; Kim SW; Kim S; Nam EJ; Kim YT
    Cancer Res Treat; 2017 Jul; 49(3):656-668. PubMed ID: 27737536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.